EP3575800A1 - Identification automatisée de bactéries et dispositif de profilage de la sensibilité aux antibiotiques - Google Patents

Identification automatisée de bactéries et dispositif de profilage de la sensibilité aux antibiotiques Download PDF

Info

Publication number
EP3575800A1
EP3575800A1 EP19177753.1A EP19177753A EP3575800A1 EP 3575800 A1 EP3575800 A1 EP 3575800A1 EP 19177753 A EP19177753 A EP 19177753A EP 3575800 A1 EP3575800 A1 EP 3575800A1
Authority
EP
European Patent Office
Prior art keywords
sample
enclosure
fluid sample
controller
articulator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19177753.1A
Other languages
German (de)
English (en)
Inventor
Jason Holder
Parker Dow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Charles Stark Draper Laboratory Inc
Original Assignee
Charles Stark Draper Laboratory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charles Stark Draper Laboratory Inc filed Critical Charles Stark Draper Laboratory Inc
Publication of EP3575800A1 publication Critical patent/EP3575800A1/fr
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
    • G01N35/04—Details of the conveyor system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/48—Automatic or computerized control
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/12—Well or multiwell plates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/50—Means for positioning or orientating the apparatus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M27/00—Means for mixing, agitating or circulating fluids in the vessel
    • C12M27/16—Vibrating; Shaking; Tilting
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/04—Mechanical means, e.g. sonic waves, stretching forces, pressure or shear stimuli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/40—Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/42—Means for regulation, monitoring, measurement or control, e.g. flow regulation of agitation speed
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/46—Means for regulation, monitoring, measurement or control, e.g. flow regulation of cellular or enzymatic activity or functionality, e.g. cell viability
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N2035/00346—Heating or cooling arrangements
    • G01N2035/00356—Holding samples at elevated temperature (incubation)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
    • G01N35/04—Details of the conveyor system
    • G01N2035/0401—Sample carriers, cuvettes or reaction vessels
    • G01N2035/0418—Plate elements with several rows of samples

Definitions

  • Bacterial infections may complicate a patient's existing medical condition, and in some cases, may lead to death. Patients suffering from various bacterial infections often present with similar symptoms, thus making it difficult to accurately identify and characterize the bacterial species or strain responsible for the infection. Accurate identification of the bacteria through conventional lab tests can be challenging and may require incubation periods of up to several days. Additionally, some bacterial strains are not amenable to culturing and in vitro analysis in light of their fastidious nature. In other situations, the observable behavior of some bacterial strains is not readily distinguishable from others. Moreover, individual strains of a particular bacterial species may exhibit resistance to otherwise effective antibiotics.
  • the present disclosure describes a fully automated system for the execution of bacteria identification and antibiotic susceptibility test (IDAST) reactions.
  • the system can automatically cycle between growth and sampling modes. In a growth mode, the system can increase a number of bacteria cells a given sample. During sample mode, the system can perform tests on the sample (or a portion thereof). For a given input sample, the system can continuously grow and test the sample to run a large number of tests. The tests can identify bacteria in the sample and profile the species of the bacteria. The system can also automatically test the bacteria's response to different levels of different antibiotics. The system can generate, based on the bacteria's response to the antibiotics, accurate Minimal Inhibitory Concentration (MIC) and Sensitive, Intermediate, and Resistant (SIR) classifications.
  • MIC Minimal Inhibitory Concentration
  • SIR Sensitive, Intermediate, and Resistant
  • At least one aspect of this disclosure is directed to a system for testing a fluid sample.
  • the system can include an enclosure.
  • the system can include a loader positioned within the enclosure and including a sample holder configured to hold a sample vessel.
  • the system can include a plate deck positioned within the enclosure and configured to support a multiwell plate including a plurality of wells.
  • the system can include a hotel incubator positioned within the enclosure and configured to receive the multiwell plate.
  • the system can include an articulator positioned within the enclosure and configured to manipulate and transfer the fluid sample within the system.
  • the system can include a testing system positioned within the enclosure and configured to identify bacteria in the fluid sample.
  • the system can include a controller configured to operate the system in a growth mode by controlling an orientation of the loader to correspond to a first predetermined tilt angle with respect to a base of the enclosure to cause the bacteria to grow in the fluid sample within the sample vessel for a predetermined growth time period.
  • the controller can be configured to operate the system in a sampling mode by controlling the articulator to transfer the fluid sample from the sample vessel to at least one well of the plurality of wells of the multiwell plate.
  • the controller can be configured to control the articulator to move the multiwell plate from the plate deck to the hotel incubator.
  • the controller can be configured to apply a bacteriophage to the fluid sample.
  • the controller can be configured to control the articulator to move the multiwell plate from the hotel incubator to the testing system after a predetermined reaction time period.
  • the controller can be configured to receive output data from the testing system. The output data can identify a characteristic of the bacteria in the fluid sample.
  • the system can include an environmental control system configured to control at least one environmental characteristic within the enclosure.
  • the environmental control system can include a vacuum pump.
  • the controller can be further configured to control the vacuum pump to maintain a predetermined pressure within the enclosure.
  • the environmental control system can include a gas pump.
  • the controller can be further configured to control the gas pump to circulate a gas within the enclosure.
  • the controller can be further configured to control the orientation of the loader to correspond to a second predetermined tilt angle, different from the first predetermined tilt angle, with respect to a base of the enclosure during the sampling mode.
  • the second predetermined tilt angle of the loader can be perpendicular to the base of the enclosure.
  • the loader can further include a shaker.
  • the controller is further configured to cause the shaker to vibrate the sample holder to agitate the fluid sample during the growth mode.
  • the articulator can further include an automated liquid handling pipette to transfer the fluid sample from the sample holder to the at least one well of the plurality of wells of the multiwell plate.
  • the articulator can further include a plate gripper to move the multiwell plate from the plate deck to the hotel incubator.
  • the hotel incubator can further include at least one slot configured to receive the multiwell plate. In some implementations, the hotel incubator can further include a heating element coupled with the at least one slot and configured to apply heat to multiwell plate within the at least one slot.
  • the bacteriophage can include a lumi-phage.
  • the testing system can be configured to measure light emitted by the bacteriophage.
  • the system can further include a filtering system configured to receive the fluid sample and to remove particles from the fluid sample.
  • the controller can be further configured to cause the filtering system to remove the particles from the fluid sample using at least one acoustophoresis, membrane-based filtering, or chemical filtering.
  • the system can further include an antibiotic within the at least one well of the multiwell plate.
  • the controller can be further configured to process the output data received from the testing system to determine a response of the bacteria to the antibiotic.
  • the fluid sample can include a first fluid sample.
  • the controller can be further configured to cause the system to process a second fluid sample simultaneously with the first fluid sample.
  • the method can include controlling, by a controller including at least one processor, an orientation of a loader including a sample holder configured to hold a sample vessel to correspond to a first predetermined tilt angle with respect to a base of an enclosure to cause bacteria to grow in the fluid sample during a predetermined growth time period.
  • the method can include controlling, by the controller, an articulator to transfer the fluid sample from the sample vessel to at least one well of a plurality of wells of a multiwell plate positioned on a plate deck within the enclosure.
  • the method can include controlling, by the controller, the articulator to move the multiwell plate from the plate deck to a hotel incubator within the enclosure.
  • the method can include applying a bacteriophage to the fluid sample.
  • the method can include controlling, by the controller, the articulator to move the multiwell plate from the hotel incubator to a testing system within the enclosure after a predetermined reaction time period.
  • the method can include receiving, by the controller, output data from the testing system. The output data can identify a characteristic of the bacteria in the fluid sample.
  • the method can include controlling, by the controller, an environmental control system configured to control at least one environmental characteristic within the enclosure.
  • the environmental control system can include a vacuum pump.
  • the method can further include controlling the vacuum pump to maintain a predetermined pressure within the enclosure.
  • the environmental control system can include a gas pump.
  • the method can further include controlling the gas pump to circulate a gas within the enclosure.
  • the loader can further include a shaker.
  • the method can further include causing the shaker to vibrate the sample holder to agitate the fluid sample during the growth mode.
  • the present solution includes a fully automated system for the execution of bacteria IDAST reactions.
  • the system enables the growth of samples to increase the number of cells to enable the system to run a large number of tests.
  • the test can identify bacteria in the sample and profile the species of the bacteria.
  • the system can also automatically test the bacteria's response to different levels of different antibiotics.
  • the system can generate, based on the bacteria's response to the antibiotics, accurate Minimal Inhibitory Concentration (MIC) and Sensitive, Intermediate, and Resistant (SIR) classifications.
  • MIC Minimal Inhibitory Concentration
  • SIR Sensitive, Intermediate, and Resistant
  • FIG. 1 illustrates a block diagram of an example system 100 to automatically perform IDAST reactions.
  • FIGS. 2-15 illustrate various views of example embodiments of the system 100 illustrated in FIG. 1 , according to illustrative implementations.
  • the system 100 includes an enclosure 102. Within the enclosure 102, the system 100 includes a loader 104. One or more articulators 106 can move samples from the loader 104 to the other areas of the system, such as the plate deck 110, hotel incubator 112, and testing system 114.
  • the system 100 can include a location for additional tips 108.
  • the system 100 can include a filtering system 116.
  • the system 100 can include a controller 118 that can control the testing system 114, the environmental control system 120, and the scanner 122.
  • the system 100 can include an enclosure 102.
  • the enclosure 102 can be a sealed or partially sealed enclosure.
  • the enclosure 102 can include one or more doors to enable samples to be loaded into the loader 104.
  • the enclosure 102 can include windows that enable visualization of the components inside the enclosure 102 or one or more of the enclosure's walls can be clear.
  • the enclosure 102 can maintain environmental conditions that support the growth and proliferation of the cells within the samples.
  • the environmental conditions can include temperature, humidity, gas mixtures (e.g., oxygen and CO2 mixtures) and concentrations, and gas pressure within the enclosure 102.
  • the environmental conditions can be set and maintained via the environmental control system 120.
  • the environmental control system 120 can include one or more gas pumps that circulate gas through the enclosure 102.
  • the environmental control system 120 can include one or more heaters that maintains a predetermined temperature within the enclosure 102.
  • the environmental control system 120 can control heating elements within the enclosure 102 or within the hotel incubator 112, or with both the enclosure 102 and the hotel incubator 112.
  • the environmental control system 120 can maintain a negative pressure within the enclosure 102 such that contaminants, cells, and other particles do not escape the enclosure 102. For example, when the enclosure's door is opened, because of the negative pressure, air flows into the enclosure 102 and not out of the enclosure 102.
  • the enclosure 102 can control the escape of particles to ensure that no biological organisms exit the testing environment within the enclosure 102.
  • the environmental control system 120 can include a vacuum pump to maintain a negative pressure within the enclosure 102.
  • Samples, such as bacteriophages and infectious microbes can be opened inside the controlled environment of the enclosure 102 and at the end of the processes performed by the system 100, the system can chemically kill the samples with strong detergents, bleach, metal chelators, and UV light exposure.
  • the system 100 can include a loader 104.
  • the loader 104 can include a plurality of sample holders 200 that are each configured to hold a sample vessel 202, which can be a blood bottle.
  • the system 100 can operate in both a growth mode and a sample mode. During the growth mode, the loader 104 can be tilted at an angle with respect to the base of the enclosure 102, as illustrated in FIG. 4 .
  • the loader 104 can include an orbital or other shaker. The loader 104 can shake, rotate, or otherwise agitate the sample. Agitation of the sample, via the loader 104, can expose the sample within the sample vessel 202 to oxygen or the other gases within the enclosure 102.
  • the system 100 can continue in the growth mode until enough cells are available in the sample to perform a desired test.
  • the system 100 can continue in the growth mode for a predetermined amount of time.
  • the growth mode can enable the system 100 to diagnose low-titer patient samples such as blood.
  • the system 100 can continue in the growth mode until a sample is withdrawn from the sample vessel 202.
  • the growth mode can be interrupted for sampling and reactions assembly followed by initiation of another cycle of the growth mode.
  • the loader 104 can rotate to a position that is substantially perpendicular to the base of the enclosure 102, as illustrated in FIG. 5 .
  • a pipette 204 can access the culture inside of the sample vessel 202.
  • the pipette 204 can be coupled to one of the actuators 106, which can position the pipette 204 over the sample vessel 202.
  • the pipette 204 can dispenses the sample from the pipette 204 into a trough 206, as illustrated in FIG. 7 . From the trough 206, sampling pipettes can distribute the sample to multiwell plates.
  • the contents of the pipette 204 can be passed to the filtering system 116.
  • the system 100 can repeatedly alternate between growth modes and sample modes for any given sample to enable data streaming.
  • Data streaming for a sample can include generating multiple sets of output data for a given sample at different time points. Each set of output data can be generated under different experimental conditions. For example, the different samples can be exposed to a different concentration of a given antibiotic.
  • the filtering system 116 can filter the sample to remove undesired particles, cells, or other material from the sample.
  • the filtering system can remove assay inhibitors from the sample.
  • the filtering system 116 can remove blood cells from the sample and leave bacteria cells within the sample.
  • the filtering system 116 can use acoustophoresis, membrane-based filtering, chemical-based filtering, or a combination thereof.
  • the filtering system 116 can use acoustophoresis and apply a standing acoustic wave to the sample.
  • the acoustic wave can drive the blood cells and bacteria to different nodes of the acoustic wave such that the blood cells can flow out of a first channel outlet and the bacteria can flow out of a second channel outlet.
  • acoustophoresis can remove about 90% of the blood cells from the sample.
  • the non-ionic detergents e.g., triton-x
  • the sample can be passed a cell trapping device, such as a filter or membrane, to trap the cells. The trapped cells can be removed from the trapping device prior to testing or can be tested while on or within the trapping device.
  • a filter can be used to remove plasma from a blood sample.
  • the sample can be transferred to multiwell plates.
  • the wells of the plate can also include a filter to filter out or capture particles or cells.
  • the articulators 106 can include automated liquid handling pipettes that can transfer the sample to the multiwell plates.
  • the liquid handling pipets can retrieve a fresh tip from the additional tips and move the sample from the filtering system 116 (or trough 206) to the multiwell plates.
  • the plates can be positioned on the plate deck 110.
  • the articulators 106 can include a plate gripper that can move the plates from the plate deck 110 to the hotel incubator 112.
  • the hotel incubator 112 can include a plurality of slots 208.
  • the hotel incubator 112 can be configured to hold or store a plurality of multiwell plates. For example, a plate can be stored into each of the slots. Each slot can be heated.
  • the bottom surface of each slot 208 can include a heating element that warms the contents of the multiwell pate in the given slot 208.
  • the bacteriophage can be applied to the samples placed in the multiwell pate. More information about the bacteriophage and testing process can be found in Appendix B of this document.
  • the articulators 106 can move the plate into the testing system 114 where light emitted from the sample can be measured.
  • the testing system 114 can also apply a strong chemical quench or reaction to kill the bacteria and other cells in the sample.
  • the system 100 can include a controller 118.
  • the controller 118 can be an application specific integrated circuit (ASIC).
  • ASIC application specific integrated circuit
  • the controller 118 can be a data processing system or a component thereof.
  • the controller 118 can be a desktop computer, laptop computer, tablet computer, mobile phone, or special purpose logic. In FIG. 14 , the controller 118 is illustrated as a desktop computer.
  • the controller 118 can control when the loader 104 transitions between the growth mode and the sampling model.
  • the controller 118 can control the movement and actions of the articulators 106.
  • the controller 118 can control the testing system 114.
  • the controller 118 can receive the output data from the testing system 114 and can perform analysis on the output data to determine, for example, whether an antibiotic applied to the sample was affective or whether the sample includes bacteria.
  • the controller 118 can run interpretative algorithms on the output data and produce a report describing identifications and antibiotic susceptibility profile.
  • the controller 118 can control the environmental control system 120.
  • the controller 118 can set the pressure differential that the environmental control system 120 maintains between the interior and exterior of the enclosure 102.
  • the controller 118 can include or can interface with a screen and other inputs that enable a user to set the conditions within the enclosure 102. Via the interface the displayed on the screen, the user can log samples into the system 100, set when tests should be run, the intervals between tests, and set what tests should be run on each of the samples.
  • the controller 118 can interface with a scanner 122.
  • each of the sample vessels 202 can include a barcode or other machine readable label.
  • a user can scan the barcode with the scanner 122 to log the sample into the system.
  • the controller 118 can log a patient identifier into a database maintained by the controller 118. With the entry, the controller 118 can add a time the sample was added to the system 100. Data from the testing system 114 that is generated from the processing of the sample can be stored by the controller 118 into the database in association with the patient identifier.
  • the controller 118 can also include and track other metadata for a given sample.
  • the metadata can include a patient sample id; position, amount, and concentrations of the antibiotics used for tests; and reporter phage identifiers.
  • the reporter phage in some instances would be lumi-phage.
  • the controller 118 can also track the times of sample growth and incubation times.
  • the controller 118 can perform scheduling of the movements, actions, and tests of the system 100. For example, different samples can be added to the loader 104 at different times. The controller 118 can generate a schedule for each of the samples. The schedule can indicate the times at which actions (e.g., movement of a multiwell pate is moved from the hotel incubator 112 to the plate deck 110 or drawing of samples from the sample vessel 202) or tests are performed by the system 100. The controller 118 can resolve conflicts in the schedules of the different samples. One example conflict is that two different samples are scheduled to be processed with the testing system 114 at the same time. The controller 118 can resolve the conflict by adjusting the time at each of the actions or tests are performed.
  • the controller 118 can compare the candidate schedule to the schedules of each of the samples already active in the system 100. The controller 118 can determine if the candidate schedule conflicts with any of the schedules of each of the samples already active in the system 100. If a conflict exists, the controller 118 can adjust (or recommend an adjustment) to the start time of the schedule generated for the new sample. Adjusting the start time of the schedule, rather than the timing of individual steps within the schedule, can enable the time between neighboring steps to remain consistent. For example, rather than adjusting an incubation time from 45 minutes to 40 minutes to avoid a conflict, adjusting the start time can enable the incubation time to remain at 45 minutes.
  • FIG. 15 illustrates a top-down view of an example implementation of the system 100 of FIG. 1 .
  • the system 100 may include a loader 104 having more sample slots 200 than are shown in other example implementations, such as those depicted in FIGS. 3 and 4 .
  • the loader 104 may include at least 20 sample slots 200, each of which may be configured to receive a respective sample vessel 202.
  • FIG. 15 also depicts a power supply 1502.
  • the power supply 1502 can be coupled with the filtering system 116.
  • the filtering system 116 may also be referred to as a sample purifier.
  • the power supply 1502 can be configured to supply electrical power to the filtering system 116.
  • electrical power from the power supply 1502 can be used by the filtering system 116 (or a component thereof) to generate one or more acoustic waves that can be used to implement acoustophoresis for separating undesired particles from the sample fluid.
  • FIG. 16 illustrates a flowchart of an example method 1600 for testing fluid samples, according to an illustrative implementation.
  • the method 1600 can be performed using a system such as the system 100 depicted in FIG. 1 .
  • a controller such as the controller 118 of the system 100.
  • FIGS. 17-28 illustrate various views of the system 100 of FIG. 1 in the stages of the method 1600 of FIG. 16 , according to illustrative implementations. Accordingly, FIG. 16 and FIGS. 17-28 are described together below.
  • the method 1600 can include controlling an orientation of the loader 104 (stage 1605).
  • the controller 118 can control the loader 104 to position or orient the loader at an angle that corresponds to a first predetermined tilt angle with respect to a base of the enclosure 102.
  • the predetermined tilt angle can be 45 degrees.
  • the predetermined tilt angle can be in the range of 40 degrees to 50 degrees, in the range of 35 degrees to 40 degrees, or in the range of 50 degrees to 55 degrees.
  • FIGS. 17-19 illustrate enlarged views of the loader 104. As illustrated in FIG. 17 , the loader 104 is in the growth mode or growth configuration.
  • the loader 104 is tilted at the first predetermined tilt angle.
  • the loader 104 can include an orbital shaker. As illustrated by the arrows 1700, the loader 104 can apply an orbital rotation to the sample vessels 202 within the loader 104 for at least a portion of the growth mode. The rotation can enable aeration of the sample.
  • the loader 104 can include a tunable controller that can be controlled directly or via the controller 118 to control the speed and amount of agitation applied by the loader's shaker, as well as to orient the loader 104 at the first predetermined tilt angle for the growth phase.
  • the method 1600 can include controlling the articulators 106 to transfer the fluid sample to a multiwell plate (stage 1610).
  • an articulator 106 can transfer the fluid sample from the sample vessel to at least one well the multiwell plate.
  • the multiwell plate can be positioned on plate deck 110 within the enclosure 102.
  • the loader 104 can first be rotated to a second predetermined tilt angle for the sampling mode or configuration.
  • the second predetermined angle can be an angle at which the loader 104 (and the sample vessel 202) is perpendicular to the base of the enclosure 102.
  • a pipette coupled with the articulators 106 can be lowered into the sample vessel 202 to collect a portion of the fluid sample therein.
  • the articulator 106 can move the fluid sample directly from the sample vessel 202 in the loader 104 to the well plate.
  • the fluid sample may be processed, for example to remove undesired particles, before being moved to the well plate.
  • the pipette can move the collected sample from the sample vessel 202 to the loading trough 206.
  • FIG. 21 illustrates a multichannel pipette 302 loading the fluid sample from the loading trough 206. As illustrated in FIG. 22 , the multichannel pipette 302 can load the sample into the inlets of the filtering system 116.
  • the multichannel pipette 302 can collect the enriched sample (e.g., the sample with blood cells removed) from the outlets of the filtering system 116, as illustrated in FIG. 23 .
  • the multichannel pipette 302 can discard and then retrieve fresh tips from the additional tips 108 between interactions with the sample.
  • FIG. 24 illustrates the multichannel pipette 302 moving the enriched sample from the outlets of the filtering system 116 to a multiwell plate 304.
  • the method 1600 can include controlling the articulator 106 to move the multiwell plate 304 from the plate deck 110 to the hotel incubator 112 (stage 1615). For example, once the sample is loaded into the plate 304, the articulator's plate gripper 306 can grab and move the plate 304 to the hotel incubator 112, as illustrated in FIG. 25 .
  • FIG. 26 illustrates an enlarged view of the hotel incubator 112 after the plate 304 is inserted into one of the hotel incubator's slots.
  • the hotel incubator 112 can extend a platform from each of the slots such that the plate gripper 306 can load the plate 304 onto the platform. The hotel incubator 112 can then retract the platform into the slot.
  • the method 1600 can include applying a bacteriophage to the fluid sample (stage 1620).
  • the bacteriophage can be a lumi-phage configured or selected to emit light.
  • the plate 304 can be preloaded with bacteriophage.
  • the bacteriophage can be added to the fluid sample when the fluid sample is introduced into the plate 304.
  • the plate 304 can also be preloaded with one or more antibiotics.
  • the bacteriophage and one or more antibiotics may be applied to the fluid sample after the fluid sample has been introduced into the plate 304.
  • the system 100 can include an automatic fluid handling system that can dispense the antibiotics and/or bacteriophage into the wells of the plate 304 before or after the sample is added to the wells.
  • the method 1600 can include controlling the articulator to move the multiwell plate 304 from the hotel incubator 112 to the testing system 114 (stage 1625).
  • the plate 304 can be moved to the testing system 114 after a predetermined amount of time (e.g., a reaction time).
  • the plate gripper 306 can move the plate 304 from the hotel incubator 112 to the testing system 114.
  • the testing system 114 can extend a loading tray 308 onto which the plate gripper 306 can deposit the plate 304, as depicted in FIG. 27 .
  • the testing system 114 can retract the loading tray 308 into the body of the testing system 114, as depicted in FIG. 28 .
  • the method 1600 can include receiving output data from the testing system 114 (stage 1630).
  • the output data can be received by the controller 118.
  • the testing system 114 can observe, determine, or identify characteristics of the fluid sample, such as by measuring light emitted from the sample (e.g., via the lumi-phage).
  • the testing system 114 can also generate output data representative of the observed, determined, identified, or measured characteristics of the fluid sample.
  • the controller 118 can receive the output data from the testing system 114 and can perform analysis on the output data to determine, for example, whether an antibiotic applied to the sample was effective, whether the sample includes bacteria, an amount of bacteria included in the sample fluid after testing, and the like.
  • the controller 118 can run interpretative algorithms on the output data and produce a report describing identifications and antibiotic susceptibility profile.
  • Recombinant detector bacteriophages may be used to identify bacteria present within a fluid sample (e.g ., whole blood, plasma, serum). Such methods entail contacting the biological sample with a recombinant detector bacteriophage, and detecting the presence of bacterial host cells infected by the recombinant detector phage, wherein the recombinant detector phage comprises a heterologous nucleic acid that encodes a detectable gene product, thereby leading to the identification of bacteria present within the biological sample.
  • recombinant detector bacteriophages may be used in methods for profiling antibiotic susceptibility of bacteria present within a biological sample (e.g ., whole blood, plasma, serum).
  • a biological sample e.g ., whole blood, plasma, serum.
  • the profiling of antibiotic susceptibility can be used with the system 100.
  • a method can include (a) contacting the biological sample with an antibiotic and a recombinant detector bacteriophage, (b) detecting the presence of bacterial host cells infected by the recombinant detector phage, wherein the recombinant detector phage can include a heterologous nucleic acid that encodes a detectable gene product, and (c) determining that the antibiotic is effective in inhibiting the bacteria present in the biological sample when the number of recombinant detector phage infected bacterial host cells is reduced relative to that observed in an untreated control sample.
  • the present disclosure provides a method for identifying at least one bacterial strain or species in a test sample obtained from a subject comprising (a) separating bacterial cells isolated from the test sample into one or more sub-samples, (b) contacting each sub-sample with one or more recombinant detector bacteriophages as disclosed herein, wherein each recombinant detector bacteriophage comprises a heterologous nucleic acid encoding one or more reporter genes, and (c) identifying at least one bacterial strain or species in the test sample by detecting the expression of the one or more reporter genes of the one or more recombinant detector bacteriophages.
  • the method for identifying at least one bacterial strain or species in a test sample does not require the culturing of bacterial cells from the test sample or a sub-sample.
  • identification of at least one bacterial strain or species includes detecting the expression of the one or more reporter genes of the one or more recombinant detector bacteriophages, e.g., detection of green fluorescence indicates the presence of bacterial species A whereas detection of blue fluorescence indicates the presence of bacterial species B.
  • the absence of at least one bacterial strain or species is identified by the lack of detectable expression of the one or more reporter genes of the one or more recombinant detector bacteriophages, e.g., undetectable expression of green fluorescence indicates the lack of bacterial species A in a test sample or sub-sample.
  • the one or more recombinant detector bacteriophages infect a single species of bacteria. In certain embodiments, the one or more recombinant detector bacteriophage infect two or more species of bacteria.
  • the species of bacteria that are infected include Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Yersinia pestis, Bacillus anthracis, Burkholderia mallei, and Franciscella tularensis. These methods can be used in combination with the system 100.
  • the one or more recombinant detector bacteriophages that infect two or more species of bacteria comprise different reporter genes, wherein the recombinant detector bacteriophages that infect the same species of bacteria comprise the same reporter gene(s).
  • detection of the expression of the reporter gene is detection of the gene product itself, e.g., a fluorescent protein.
  • detection of the expression of the reporter gene is detection of an enzymatic reaction requiring the expression of the reporter gene, e.g., expression of luciferase to catalyze luciferin to produce light.
  • the expression of the one or more reporter genes is detected in about 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90 minutes or any time between any two of the preceding values after contacting a sub-sample with the one or more recombinant detector bacteriophages using the system 100.
  • the present disclosure provides a method for determining the antibiotic susceptibility of a bacterial strain or species in a test sample obtained from a subject comprising (a) separating bacterial cells isolated from the test sample into a plurality of sub-samples, (b) contacting the plurality of sub-samples with a recombinant detector bacteriophage and at least one antibiotic, wherein the recombinant detector bacteriophage comprises a heterologous nucleic acid encoding a reporter gene, and (c) detecting the expression of the reporter gene of the recombinant detector bacteriophage in the presence of each antibiotic.
  • the method further includes determining that the bacterial strain or species in the test sample is susceptible to an antibiotic if the reporter gene expression of the recombinant detector bacteriophage in the antibiotic treated sub-sample is decreased relative to that observed in a control sub-sample that is not treated with the antibiotic. In other embodiments, the method further comprises determining that the bacterial strain or species in the test sample is resistant to an antibiotic if the reporter gene expression of the recombinant detector bacteriophage in the antibiotic treated sub-sample is comparable to that observed in a control sub-sample that is not treated with the antibiotic.
  • the method for determining the antibiotic susceptibility of a bacterial strain or species in a test sample does not require the culturing of bacterial cells from a test sample or a sub-sample. These methods can be used in combination with the system 100.
  • references to implementations or elements or acts of the systems and methods herein referred to in the singular may also embrace implementations including a plurality of these elements, and any references in plural to any implementation or element or act herein may also embrace implementations including only a single element.
  • References in the singular or plural form are not intended to limit the presently disclosed systems or methods, their components, acts, or elements to single or plural configurations.
  • References to any act or element being based on any information, act or element may include implementations where the act or element is based at least in part on any information, act, or element.
  • any implementation disclosed herein may be combined with any other implementation or embodiment, and references to "an implementation,” “some implementations,” “one implementation” or the like are not necessarily mutually exclusive and are intended to indicate that a particular feature, structure, or characteristic described in connection with the implementation may be included in at least one implementation or embodiment. Such terms as used herein are not necessarily all referring to the same implementation. Any implementation may be combined with any other implementation, inclusively or exclusively, in any manner consistent with the aspects and implementations disclosed herein.
  • references to "or” may be construed as inclusive so that any terms described using “or” may indicate any of a single, more than one, and all of the described terms.
  • a reference to "at least one of 'A' and 'B'” can include only 'A', only 'B', as well as both 'A' and 'B'.
  • Such references used in conjunction with “comprising" or other open terminology can include additional items.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Sustainable Development (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Clinical Laboratory Science (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Computer Hardware Design (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Mechanical Engineering (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP19177753.1A 2018-06-01 2019-05-31 Identification automatisée de bactéries et dispositif de profilage de la sensibilité aux antibiotiques Withdrawn EP3575800A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862679617P 2018-06-01 2018-06-01

Publications (1)

Publication Number Publication Date
EP3575800A1 true EP3575800A1 (fr) 2019-12-04

Family

ID=66751910

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19177753.1A Withdrawn EP3575800A1 (fr) 2018-06-01 2019-05-31 Identification automatisée de bactéries et dispositif de profilage de la sensibilité aux antibiotiques

Country Status (2)

Country Link
US (1) US11407970B2 (fr)
EP (1) EP3575800A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102019134003A1 (de) * 2019-12-11 2021-06-17 Aixinno Limited Verfahren und Vorrichtung zum Kultivieren biologischer Zellen
WO2024259544A1 (fr) * 2023-06-19 2024-12-26 Universidad De La Frontera Dispositif modulaire pour cultiver des biopellicules et appliquer un stress mécanique sur les biopellicules

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0773988A1 (fr) * 1995-06-06 1997-05-21 Becton, Dickinson and Company Appareil compact de culture de sang
EP1655609A1 (fr) * 2004-11-04 2006-05-10 F.Hoffmann-La Roche Ag Ensemble support d'eprouvettes comprenant une partie mouvant pour agiter d'échantillon
WO2008131230A1 (fr) * 2007-04-18 2008-10-30 Cornell University Procédé et appareil de détection de micro-organisme
US20090286225A1 (en) * 2004-02-13 2009-11-19 Microphagetm Incorporated Method and apparatus for bacteriophage-based diagnostic assays
US20120021452A1 (en) * 2010-07-22 2012-01-26 Biomerieux, Inc. Belt Agitation System For Culture Bottles
US20160160260A1 (en) * 2014-12-05 2016-06-09 Bacterioscan Ltd Multi-Sample Laser-Scatter Measurement Instrument With Incubation Feature And Systems For Using The Same
US9441204B2 (en) * 2008-04-03 2016-09-13 Colorado School Of Mines Compositions and methods for detecting Yersinia pestis bacteria
WO2018007939A1 (fr) * 2016-07-04 2018-01-11 Alifax S.R.L. Appareil intégré pour analyses de diagnostic

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8703492B2 (en) * 2007-04-06 2014-04-22 Qiagen Gaithersburg, Inc. Open platform hybrid manual-automated sample processing system
KR101767336B1 (ko) * 2015-07-09 2017-08-10 사회복지법인 삼성생명공익재단 자동 세포 배양기 및 그 배양기의 동작 방법
BR112018071543A2 (pt) * 2016-04-22 2019-02-26 SeLux Diagnostics, Inc. execução do teste de suscetibilidade antimicrobiana e sistemas e métodos relacionados
US11156627B2 (en) * 2016-06-20 2021-10-26 Genesis Technologies Limited Automated cell processing systems and methods

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0773988A1 (fr) * 1995-06-06 1997-05-21 Becton, Dickinson and Company Appareil compact de culture de sang
US20090286225A1 (en) * 2004-02-13 2009-11-19 Microphagetm Incorporated Method and apparatus for bacteriophage-based diagnostic assays
EP1655609A1 (fr) * 2004-11-04 2006-05-10 F.Hoffmann-La Roche Ag Ensemble support d'eprouvettes comprenant une partie mouvant pour agiter d'échantillon
WO2008131230A1 (fr) * 2007-04-18 2008-10-30 Cornell University Procédé et appareil de détection de micro-organisme
US9441204B2 (en) * 2008-04-03 2016-09-13 Colorado School Of Mines Compositions and methods for detecting Yersinia pestis bacteria
US20120021452A1 (en) * 2010-07-22 2012-01-26 Biomerieux, Inc. Belt Agitation System For Culture Bottles
US20160160260A1 (en) * 2014-12-05 2016-06-09 Bacterioscan Ltd Multi-Sample Laser-Scatter Measurement Instrument With Incubation Feature And Systems For Using The Same
WO2018007939A1 (fr) * 2016-07-04 2018-01-11 Alifax S.R.L. Appareil intégré pour analyses de diagnostic

Also Published As

Publication number Publication date
US11407970B2 (en) 2022-08-09
US20190367863A1 (en) 2019-12-05

Similar Documents

Publication Publication Date Title
JP7842691B2 (ja) 自動細胞培養用のシステム及び方法
US6673595B2 (en) Automated cell management system for growth and manipulation of cultured cells
US11371072B2 (en) Method and apparatus for identification of bacteria
JP2021509803A (ja) フロースルー型エレクトロポレーションデバイスを含む自動細胞処理方法、モジュール、機器、及びシステム
JP7244961B2 (ja) 手順条件の適応サイバネティック制御を用いた生物学的実験を実施するシステムおよび方法
EP2600156A1 (fr) Dispositif d'analyse d'acides nucléiques
US20060281143A1 (en) Method and apparatus for automatic cell and biological sample preparation and detection
JP5313218B2 (ja) 細菌検査システム
WO2010040831A1 (fr) Analyse génétique dans des micropuits
CN105745545A (zh) 包括用于包含至少一个实验室样本的处理的处理过程中的部分问题的仪器控制处理的至少两个实验室仪器的系统、实验室仪器和方法
EP2306204A1 (fr) Analyseur d'acide nucléique, analyseur automatique et procédé d'analyse
US11407970B2 (en) Automated bacteria identification and antibiotic susceptibility profiling device
KR20220024766A (ko) 대변 샘플 처리 시스템 및 방법
WO2022183127A1 (fr) Test de sensibilité aux antibiotiques sur un même échantillon et compositions, procédés et systèmes associés
CN1668766A (zh) 用于多聚核苷酸检测和定量的设备
US20190218591A1 (en) Systems and methods for scheduling and sequencing automated testing procedures
US11654437B2 (en) Assay cartridg for molecular diagnosis
JP2011147403A (ja) 細菌検査装置及び細菌検査方法
WO2024052679A1 (fr) Système de biotraitement
JP2025504826A (ja) 抗菌剤感受性試験のためのシステム、方法、および装置
US20030129739A1 (en) Analytical method and apparatus
US20230417786A1 (en) Fully automated sample processing platform from extraction to sequencing
EP4541879A1 (fr) Récipient pour analyse de cellule unique et procédé d'analyse de cellule unique l'utilisant
JP5385638B2 (ja) バイオクリーンルームの清浄度管理方法及びバイオクリーンルーム
WO2022241243A1 (fr) Techniques de détection et de quantification de bactéries vivantes et mortes dans un échantillon de fluide

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200605